IDiyas

For the Inventor, By the Inventor

Cambridge, United Kingdom

Martyn Frederickson

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 124(Granted Patents)


Company Filing History:

goldMedal16 out of 123 
 
Astex Therapeutics Limited
 patents

Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11866428 - Bicyclic heterocycle compounds and their uses in therapy (2024-01-09),
2. 9914719 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2018-03-13),
3. 9676768 - Bicyclic heterocycle compounds and their uses in therapy (2017-06-13),
4. 9428439 - Hydrobenzamide derivatives as inhibitors of Hsp90 (2016-08-30),
5. 9018214 - Bicyclic heterocycle compounds and their uses in therapy (2015-04-28),
6. 8816087 - Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 (2014-08-26),
7. 8796244 - Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases (2014-08-05),
8. 8779132 - Pharmaceutical compounds (2014-07-15),
9. 8664218 - Pharmaceutical compounds (2014-03-04),
10. 8653084 - Hydrobenzamide derivatives as inhibitors of Hsp90 (2014-02-18),
11. 8530469 - Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 (2013-09-10),
12. 8383619 - Pharmaceutical compounds (2013-02-26),
13. 8106057 - Dihydroxyphenyl isoindolylmethanones (2012-01-31),
14. 8101648 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2012-01-24),
15. 7754725 - Dihydroxyphenyl isoindolymethanones (2010-07-13),

Title: Inventor Spotlight: Martyn Frederickson

Introduction

Martyn Frederickson, a prominent inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceutical innovation. With 16 patents to his name, he has demonstrated a commitment to advancing medical therapies through his inventive processes.

Latest Patents

Among his latest innovations are two noteworthy patents that showcase his expertise. The first is focused on bicyclic heterocycle compounds and their therapeutic uses. This patent describes novel compounds that can be utilized in treating diseases such as cancer. The second patent pertains to hydroxybenzamide derivatives, which function as inhibitors of HSP90, a protein that plays a critical role in cancer cell growth. Both patents reflect Frederickson's dedication to developing effective treatments for significant health challenges.

Career Highlights

Martyn Frederickson is currently affiliated with Astex Therapeutics Limited, an organization known for its cutting-edge pharmaceutical research. His work has not only contributed to his own professional achievements but has also paved the way for advancements in therapeutic applications in the industry.

Collaborations

Frederickson collaborates with talented professionals such as Gianni Chessari and Alison Jo-Anne Woolford, further enriching the research environment at Astex Therapeutics Limited. These collaborations contribute to the innovative atmosphere that drives their success in drug discovery and development.

Conclusion

In summary, Martyn Frederickson is a distinguished inventor whose 16 patents reflect his innovative spirit and commitment to improving therapeutic options. His work at Astex Therapeutics Limited, along with his collaboration with esteemed colleagues, exemplifies his role in advancing the field of medicine through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…